G306-0262 Screening compound: N-(2-chloro-4,6-dimethoxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-sulfonamide

G306-0262 Screening compound: N-(2-chloro-4,6-dimethoxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-sulfonamide
G306-0262 Screening compound: N-(2-chloro-4,6-dimethoxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G306-0262
N-(2-chloro-4,6-dimethoxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G306-0262

Molecular Formula

C17H16ClN3O6S (C17 H16 ClN3 O6 S)

Compound Name

N-(2-chloro-4,6-dimethoxyphenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepine-7-sulfonamide

IUPAC name

N-(2-chloro-46-dimethoxyphenyl)-24-dioxo-2345-tetrahydro-1H-15-benzodiazepine-7-sulfonamide

SMILES

COc(cc1OC)cc(Cl)c1NS(c(cc1)cc(NC(C2)=O)c1NC2=O)(=O)=O

InChI

InChI=1S/C17H16ClN3O6S/c1-26-9-5-11(18)17(14(6-9)27-2)21-28(24,25)10-3-4-12-13(7-10)20-16(23)8-15(22)19-12/h3-7,21H,8H2,1-2H3,(H,19,22)(H,20,23)

InChI Key

HJQZLUYZTPTMQY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14996304

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

425.85

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.608

Distribution Coefficient, logD

-0.953

Water Solubility, LogSw

-2.59

Polar Surface Area

104.719

Acid Dissociation Constant (pKa)

5.85

Base Dissociation Constant (pKb)

-2.22

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.60

G306-0262 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

Bromodomain Modulators Library (5801 compounds)

Protein-Protein Interaction Library (218420 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Epigenetics Focused Set (26518 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G306-0262 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G306-0262?
Check Price and Availability of G306-0262, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G306-0262 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G306-0262
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G306-0262
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G306-0262 available by request